Dev Paul, DO, PhD, FACP
Medical Oncologist


Denver - Rose Medical Center Campus
4700 E. Hale Pkwy., Ste. 400Denver, Colorado 80220
303-321-0302
SECONDARY LOCATION(S)
Denver - Rose Medical Center Campus Breast Specialists
4700 E. Hale Pkwy., Ste. 400Denver, Colorado 80220
303-376-5020
About Dev Paul, DO, PhD, FACP
Dr. Dev Paul is a board-certified medical oncologist with advanced sub-specialty expertise in breast cancer. As a breast oncologist, he treats breast cancer patients with cutting-edge treatments such as chemotherapy, immunotherapy, hormone therapy, and clinical trials. Dr. Paul practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines.
He works closely with breast surgeons, radiation oncologists, plastic surgeons, and other sub-specialists and participates in a weekly breast tumor board conference. During these tumor boards, cancer experts collaborate and review cases, share knowledge, and determine the best possible treatment for each patient. Dr. Paul develops customized cancer treatment plans for each of his patients that incorporate cutting-edge therapies.
Advanced Practice Providers Working With Dr. Paul
Board Certifications
Internal Medicine
Medical Oncology
Specialties
- Breast Cancer
- Angiosarcoma of the Breast
- Ductal Carcinoma in Situ (DCIS)
- HER2+ Breast Cancers
- Inflammatory Breast Cancer
- Invasive Breast Cancer (IDC/ILC)
- Lobular Carcinoma in Situ (LCIS)
- Male Breast Cancer
- Metastatic Breast Cancer
- Paget Disease of the Breast
- Pregnancy Associated Breast Cancer
- Triple-Negative Breast Cancer
- Breast Cancer Clinical Trials
Education
Fellowship
Medical Oncology with Breast Cancer Specialization, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD
Residency
Internal Medicine, University of Wisconsin, Madison, WI
Medical School
DO, Ph.D., Pathology, Medical Scientist Training Program, Michigan State University, East Lansing, MI
Patient Care Philosophy
I provide compassionate, state-of-the-art care for breast cancer patients.